Anthrax Vaccine-Induced Antibodies Provide Cross-Species Prediction of Survival to Aerosol Challenge

Avidity of Serogroup A Meningococcal IgG Antibodies after Immunization with Different Doses of a Tetravalent A/C/Y/W135 Polysaccharide Vaccine

(2011) G. K. Bårnes et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials

(2010) Stephen D. Soroka et al.   BIOLOGICALS

Coefficients of Determination in Logistic Regression Models—A New Proposal: The Coefficient of Discrimination

(2009) Tue Tjur   AMERICAN STATISTICIAN

Efficacy of recombinant anthrax vaccine againstBacillus anthracisaerosol spore challenge: Preclinical evaluation in rabbits and Rhesus monkeys

(2009) Anil Chawla et al.   Biotechnology Journal

Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule

(2009) Nancy J. Sullivan et al.   NATURE REVIEWS MICROBIOLOGY

Related Causal Frameworks for Surrogate Outcomes

(2008) Marshall M. Joffe et al.   BIOMETRICS

Interlaboratory Comparison of Results of an Anthrax Lethal Toxin Neutralization Assay for Assessment of Functional Antibodies in Multiple Species

(2008) K. S. Omland et al.   Clinical and Vaccine Immunology

Vaccines: Correlates of Vaccine‐Induced Immunity

(2008) Stanley A. Plotkin   CLINICAL INFECTIOUS DISEASES

Effects of a Reduced Dose Schedule and Intramuscular Administration of Anthrax Vaccine Adsorbed on Immunogenicity and Safety at 7 MonthsA Randomized Trial

(2008) Nina Marano   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization

(2008) Han Li et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Evaluating a surrogate endpoint at three levels, with application to vaccine development

(2007) Peter B. Gilbert et al.   STATISTICS IN MEDICINE